SEC Info - Nymox Pharmaceutical Corp - ‘20-F’ for 12/31/13

SEC Info℠

Home

Help

Please Sign In

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/13

On: Friday, 3/14/14, at 12:02pm ET · For: 12/31/13 · Accession #: 1176256-14-92 · File #: 1-12033

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/14/14  Nymox Pharmaceutical Corp         20-F       12/31/13    6:1.1M                                   e3 Fil… Computershare/FA

Annual Report by a Foreign Private Issuer — Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report for the Fiscal Year Ended December    HTML    826K 
                          31, 2013                                               
 2: EX-4.W      Common Stock Private Purchase Agreement Dated       HTML    105K 
                          November 1, 2013                                       
 5: EX-13.A     Sox Section 906 CEO Certification                   HTML      7K 
 6: EX-13.B     Sox Section 906 CFO Certification                   HTML      7K 
 3: EX-12.A     Sox Section 302 CEO Certification                   HTML     11K 
 4: EX-12.B     Sox Section 302 CFO Certification                   HTML     11K

Filing Submission 0001176256-14-000092 – SGML Text

Original SGML Text submitted by:	e3 Filing - Computershare/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/13

On: Friday, 3/14/14, at 12:02pm ET · For: 12/31/13 · Accession #: 1176256-14-92 · File #: 1-12033

Previous ‘20-F’: ‘20-F’ on 3/15/13 for 12/31/12 · Next: ‘20-F’ on 3/31/15 for 12/31/14 · Latest: ‘20-F’ on 5/2/23 for 12/31/22

Annual Report by a Foreign Private Issuer — Form 20-FFiling Table of Contents

To view the SGML, please refresh this page.

Annual Report by a Foreign Private Issuer — Form 20-F
Filing Table of Contents

To view the SGML, please refresh
this page.